TY - JOUR
T1 - Factors influencing the effects of policies and interventions to promote the appropriate use of medicines in high-income countries
T2 - A rapid realist review
AU - Charbonneau, Mathieu
AU - Morgan, Steven G.
AU - Gagnon, Camille
AU - Sadowski, Cheryl A.
AU - Silvius, James L.
AU - Tannenbaum, Cara
AU - Turner, Justin P.
N1 - Funding Information:
This work was funded, through a Postdoctoral Fellowship at the Canadian Medication Appropriateness and Deprescribing Network, by the Canadian Institutes of Health Research and the Chaire pharmaceutique Michel-Saucier en santé et vieillissement (Université de Montréal).
Publisher Copyright:
© 2024 The Authors
PY - 2024/4
Y1 - 2024/4
N2 - Background: The appropriate use of medicines has long been recognized as a fundamental component of medicine policies. We aimed to extract lessons from published research on how policy contexts and mechanisms can affect the outcomes of national- or health-system level interventions to promote appropriate medicine use (defined as an increase in underutilized medications or decrease in inappropriate medication use). Methods: We conducted a rapid realist review of published evidence concerning system-level policies to promote the appropriate use of medicines in high-income countries with universal prescription drug coverage. We searched MEDLINE and Embase to identify relevant publications. We used a realist evaluation framework to identify contexts, mechanisms, and outcomes for each intervention and to hypothesize which policy contexts and mechanisms supported successful outcomes in terms of relative changes in the prevalence of use of the specific medication classes targeted. Results: From 1,318 identified studies, 18 met our inclusion criteria. 13 distinct policies were identified. Three main policy-related factors underpinned successful interventions: involving providers and patients through program interventions; central coordination through national agencies dedicated to medicine policies; and the establishment of an explicit and integrated national medicine policy strategy. Conclusion: Policymakers can improve coordination of national pharmaceutical policies to reduce harms from inappropriate medicines use, thus improving health outcomes through cost-effective programs.
AB - Background: The appropriate use of medicines has long been recognized as a fundamental component of medicine policies. We aimed to extract lessons from published research on how policy contexts and mechanisms can affect the outcomes of national- or health-system level interventions to promote appropriate medicine use (defined as an increase in underutilized medications or decrease in inappropriate medication use). Methods: We conducted a rapid realist review of published evidence concerning system-level policies to promote the appropriate use of medicines in high-income countries with universal prescription drug coverage. We searched MEDLINE and Embase to identify relevant publications. We used a realist evaluation framework to identify contexts, mechanisms, and outcomes for each intervention and to hypothesize which policy contexts and mechanisms supported successful outcomes in terms of relative changes in the prevalence of use of the specific medication classes targeted. Results: From 1,318 identified studies, 18 met our inclusion criteria. 13 distinct policies were identified. Three main policy-related factors underpinned successful interventions: involving providers and patients through program interventions; central coordination through national agencies dedicated to medicine policies; and the establishment of an explicit and integrated national medicine policy strategy. Conclusion: Policymakers can improve coordination of national pharmaceutical policies to reduce harms from inappropriate medicines use, thus improving health outcomes through cost-effective programs.
KW - Appropriate medicine use
KW - National medicines policies
KW - Pharmaceutical policy
KW - Prescribing appropriateness
KW - Realist review
UR - http://www.scopus.com/inward/record.url?scp=85186889530&partnerID=8YFLogxK
U2 - 10.1016/j.healthpol.2024.105027
DO - 10.1016/j.healthpol.2024.105027
M3 - Review Article
AN - SCOPUS:85186889530
SN - 0168-8510
VL - 142
JO - Health Policy
JF - Health Policy
M1 - 105027
ER -